The abstract is read at the publisher; the summary is JClub's.
Sympathetic nerve-derived noradrenaline drives lung fibrosis in the bleomycin mouse model by promoting ADRA1D+ α-SMA+ effector fibroblasts, with therapeutic benefit from blocking α1 receptors.
- Why it matters: Pulmonary fibrosis progresses with irreversible scarring, but how sympathetic signaling reshapes fibroblast programs in fibrotic lung regions remains incompletely understood.
- What they did: Using optical clearing and whole-lung imaging in bleomycin mice plus multichannel immunofluorescence in patient explants (IPF and SSc-ILD), the study tested sympathetic nerve effects in co-culture and used neurotrophic receptor tyrosine kinase 1 deletion, Adra1d deletion, and noradrenaline receptor inhibition in mice and human precision-cut lung slices.
- The result: Noradrenaline receptor blockade and Adra1d deletion mitigated collagen accumulation and pathologic remodeling, and single-cell RNA-seq reanalysis linked α1-adrenoreceptor antagonist-responsive, disease-specific effector fibroblast programs to IPF and SSc-ILD.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.